DOI: 10.12890/2026_007583
Dissociated cholestasis at onset of systemic lupus erythematosus in a male patient: an atypical case
Authors
jdyf73@gmail.com
Keywords
Dissociated cholestasis, systemic lupus erythematosus, alkaline phosphatase, polyserositisAbstract
Introduction: Biliary involvement in systemic lupus erythematosus is uncommon, and dissociated cholestasis, defined as elevated alkaline phosphatase and gamma-glutamyl transferase with normal bilirubin, has rarely been described.
Case description: A 41-year-old diabetic man without cutaneous manifestations presented with myalgia and progressive, disabling muscle weakness without creatine kinase elevation. On admission, he had dissociated cholestasis with normal transaminases and concurrent glomerular involvement (proteinuria and haematuria); magnetic resonance cholangiopancreatography was normal. Several days later, he developed rapidly progressive polyserositis requiring urgent pericardiotomy. Strongly positive antinuclear and anti-double-stranded DNA antibodies supported the diagnosis of systemic lupus erythematosus. He improved clinically and biochemically with methylprednisolone and hydroxychloroquine, followed by azathioprine at discharge; alkaline phosphatase and proteinuria normalised at six months, while gamma-glutamyl transferase remained elevated.
Discussion: A normal cholangiogram, the acute course and improvement with immunosuppression made primary sclerosing cholangitis unlikely, although its small-duct variant cannot be excluded without liver biopsy, which was not performed. In the literature reviewed, the dissociated pattern in systemic lupus erythematosus has rarely been described.
Conclusion: In this patient, dissociated cholestasis was a presenting manifestation of systemic lupus erythematosus that coincided with renal involvement and preceded severe serositis. It may be an early marker of lupus activity, a hypothesis that requires validation in a larger series.
References
- Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331:1480–1491. doi: 10.1001/jama.2024.2315.
- Williamson L, Hao Y, Basnayake C, Oon S, Nikpour M. Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus. Semin Arthritis Rheum. 2024;69:152567. doi: 10.1016/j.semarthrit.2024.152567.
- Takahashi A, Abe K, Saito R, Iwadate H, Okai K, Katsushima F, et al. Liver dysfunction in patients with systemic lupus erythematosus. Intern Med. 2013;52:1461–1465. doi: 10.2169/internalmedicine.52.9458.
- Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18–35. doi: 10.1038/ajg.2016.517.
- González-Regueiro JA, Cruz-Contreras M, Merayo-Chalico J, Barrera-Vargas A, Ruiz-Margáin A, Campos-Murguía A, et al. Hepatic manifestations in systemic lupus erythematosus. Lupus. 2020;29:813–824. doi: 10.1177/0961203320923398.
- Naitoh I, Isayama H, Akamatsu N, Mizuno S, Fujisawa T, Nakamoto N, et al. The 2024 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol. 2025;60:1221–1231. doi: 10.1007/s00535-025-02265-5.
- Oh DC, Ng TM, Ho J, Leong KP. Systemic lupus erythematosus with concurrent protein-losing enteropathy and primary sclerosing cholangitis: a unique association. Lupus. 2006;15(2):102-4. doi: 10.1191/0961203306lu2251cr.
- Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012;39(4):759-69. doi: 10.3899/jrheum.111061.
- Chow WH, Lam MS, Kwan WK, Ng WF. Cholestatic hepatitis: a rare hepatic manifestation of systemic lupus erythematosus. Hong Kong Med J. 1997;3:331–334.
- Chouchana L, Terris B, Sogni P, Treluyer JM, Costedoat-Chalumeau N, Loriot MA. Azathioprine-induced vanishing bile duct syndrome: the value of early thiopurine metabolism assessment. Br J Clin Pharmacol. 2023;89:2625–2630. doi: 10.1111/bcp.15797.
